Stock UniverseDerived research view · source repositories remain read-only

C4 Therapeutics, Inc. (CCCC)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
29.34
Global Rank
2130
Market Cap
261.67M
Latest Close
3.85
RS Composite
31.46% · G#278

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
31.40%
3M
26.64%
6M
37.01%
1Y
150.00%
3Y
13.57%
5Y
-89.58%
10Y
-84.90%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.12M · 30-day average: 2.81M · Max drawdown over stored range: -97.82%

Research Snapshot

Relative Strength vs SPX

RS Composite31.46%
20D RS28.56%
60D RS19.79%
120D RS44.58%
Global RS Rank278 · 91.71% percentile
Watch+Speculative RS Rank162 · 92.27% percentile
Group ScopeWatch+Speculative
Primary RS Rank44 · 90.39% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank335 / 701
Primary Percentile52.35
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for CCCC.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue33.19545.78531.09620.75635.58435.947
Revenue Growth (YoY)55.255%37.927%-32.083%-33.252%71.44%1.02%
Gross Profit-45.245-48.88-86.745-96.95-75.053
Operating Income-60.449-82.134-129.534-139.031-117.177
Free Cash Flow-67.899-88.242-111.435-108.546-65.337-99.301
Free Cash Flow Per Share-5.972-1.917-2.281-2.187-0.942-1.1979208405232489
EPS (Diluted) GAAP-5.834044-1.822086-2.623222-2.66905-1.518112
EPS Growth
EPS Non-GAAP
Gross Margin-136.301%-106.76%-278.959%6900%-210.918%100%
Operating Margin-182.103%-179.391%-416.562%-669.835%-329.297%-320.533%
Profit Margin-199.834%-183.23%-412.191%-638.336%-295.964%-291.7434%
Free Cash Flow Margin-204.546%-192.731%-358.358%-522.962%-183.613%-276.2428%
Shares Outstanding (Diluted)11.370346.041748.861749.640569.37382.8945
Shares Change (YoY)728.798%304.929%6.125%1.594%39.751%19.491%

SEC Quarterly Fundamentals

No processed quarterly rows for CCCC.